• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环型疫苗接种和病媒控制作为亚洲某城市潜在黄热病疫情的控制策略。

Ring vaccination and vector control as control strategies for potential yellow fever outbreak in an Asian city.

作者信息

Yang Guo Jing, Song Haolong, Lim Jue Tao, Janhavi A, Gan Gregory, Tong Guan, Ma Pei, Lim Wei Han Nigel, Bin Mohd Aziz Muhammad Hafiz, Dickens Borame L

机构信息

Saw Swee Hock School of Public Health, National University of Singapore, Singapore.

Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.

出版信息

Infect Dis Model. 2025 Jul 20;10(4):1398-1417. doi: 10.1016/j.idm.2025.07.008. eCollection 2025 Dec.

DOI:10.1016/j.idm.2025.07.008
PMID:40792289
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12337663/
Abstract

BACKGROUND

Yellow Fever (YF) importation remains an active risk to Southeast Asia. This study aims to determine the effectiveness of vector control and ring vaccination as containment strategies.

METHODS

We modelled a YF outbreak in Singapore over 1 year using a metapopulation vector-host spatial model to explore the impact of a potential epidemic and intervention effectiveness. 30 different scenarios were examined by varying the vector to human ratio ([1, 3, 6]), vaccination coverage ([10 %, 50 %, 90 %]) and delay in vaccine rollout ([7, 14, 30 days]), including three non-vaccination scenarios with the vector-to-human ratio m ([1, 3, 6]).

RESULTS

Vector control has a significant protective effect with an 89 % reduction in the cumulative number of exposed cases at Day 365 when lowering from 6 to 1 in the baseline scenario without ring vaccination. Vaccination coverage levels of 90 %, 50 %, and 10 % reduce the cumulative number of exposed cases by 88 %, 56 %, and 12 %, respectively, compared to baseline, when fixing m = 3 and a 7-day rollout delay. A greater number of severe infections and deaths can be mitigated by decreasing the ratio m compared to ring vaccination strategies. The marginal gains in averting the number of infections and deaths are most significant when m is decreased, followed by increased vaccination coverage and reduced intervention delay as R is proportional to . This highlights the central role of vector control. Our findings suggested that ring vaccination is effective under lower mosquito-to-human ratios up to 1-week post-detection, with vaccination coverage of at least 50 %. Under these settings, vaccine doses equal to 25 % of the total population are needed to contain the initial outbreak, allowing time to monitor its progress and restock the supply. After that, further interventions where YF has not yet been declared endemic.

CONCLUSION

Our findings suggested that ring vaccination is effective under lower mosquito-to-human ratios up to 1-week post-detection, with vaccination coverage of at least 50 %. After that, further interventions are required to bring the effective reproduction number under 1, highlighting the need for rapid response and containment, preparation in the stockpiling of vaccines, and continual suppression of mosquito vector populations when faced with the risk of YF importation and outbreak.

摘要

背景

黄热病(YF)输入仍是东南亚面临的一项现实风险。本研究旨在确定病媒控制和环状疫苗接种作为遏制策略的有效性。

方法

我们使用异质种群病媒-宿主空间模型对新加坡一年内的黄热病疫情进行建模,以探讨潜在疫情的影响和干预效果。通过改变病媒与人类的比例([1, 3, 6])、疫苗接种覆盖率([10%、50%、90%])以及疫苗推出延迟时间([7、14、30天]),研究了30种不同的情景,包括三种无疫苗接种情景,病媒与人类的比例为m([1, 3, 6])。

结果

在无环状疫苗接种的基线情景下,当病媒与人类的比例从6降至1时,病媒控制具有显著的保护作用,在第365天时暴露病例的累积数量减少了89%。当固定m = 3且疫苗推出延迟7天时,与基线相比,疫苗接种覆盖率达到90%、50%和10%时,暴露病例的累积数量分别减少了88%、56%和12%。与环状疫苗接种策略相比,降低比例m可减轻更多的严重感染和死亡。当m降低时,避免感染和死亡人数的边际收益最为显著,其次是提高疫苗接种覆盖率和缩短干预延迟时间,因为R与 成正比。这突出了病媒控制的核心作用。我们的研究结果表明,在检测后长达1周的较低蚊媒与人类比例情况下,环状疫苗接种是有效的,疫苗接种覆盖率至少为50%。在这些情况下,需要相当于总人口25%的疫苗剂量来控制初始疫情,以便有时间监测疫情进展并补充供应。之后,在黄热病尚未宣布为地方病的情况下需要采取进一步干预措施。

结论

我们的研究结果表明,在检测后长达1周的较低蚊媒与人类比例情况下,环状疫苗接种是有效的,疫苗接种覆盖率至少为50%。之后,需要采取进一步干预措施将有效繁殖数R降至1以下,这凸显了面对黄热病输入和疫情风险时快速应对和遏制、储备疫苗以及持续抑制蚊媒数量的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/113b/12337663/7d2ff971ff16/fx2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/113b/12337663/6e9b481d0fe5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/113b/12337663/f4a836d26b72/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/113b/12337663/a3c5dbada656/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/113b/12337663/4f0d1e786123/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/113b/12337663/74755318cbbe/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/113b/12337663/59d3efd2747c/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/113b/12337663/4ac474f6a340/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/113b/12337663/adc569c0eaf5/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/113b/12337663/6494f465f804/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/113b/12337663/7d2ff971ff16/fx2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/113b/12337663/6e9b481d0fe5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/113b/12337663/f4a836d26b72/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/113b/12337663/a3c5dbada656/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/113b/12337663/4f0d1e786123/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/113b/12337663/74755318cbbe/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/113b/12337663/59d3efd2747c/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/113b/12337663/4ac474f6a340/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/113b/12337663/adc569c0eaf5/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/113b/12337663/6494f465f804/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/113b/12337663/7d2ff971ff16/fx2.jpg

相似文献

1
Ring vaccination and vector control as control strategies for potential yellow fever outbreak in an Asian city.环型疫苗接种和病媒控制作为亚洲某城市潜在黄热病疫情的控制策略。
Infect Dis Model. 2025 Jul 20;10(4):1398-1417. doi: 10.1016/j.idm.2025.07.008. eCollection 2025 Dec.
2
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.肺炎球菌结合疫苗的免疫原性和血清效力:系统评价和网络荟萃分析。
Health Technol Assess. 2024 Jul;28(34):1-109. doi: 10.3310/YWHA3079.
3
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
Interventions targeted at women to encourage the uptake of cervical screening.针对女性的干预措施,以鼓励她们接受宫颈癌筛查。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.
8
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.接种人乳头瘤病毒预防性疫苗以预防宫颈癌及其癌前病变。
Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.

本文引用的文献

1
The biting rate of Aedes aegypti and its variability: A systematic review (1970-2022).埃及伊蚊的叮咬率及其变异性:系统评价(1970-2022 年)。
PLoS Negl Trop Dis. 2023 Aug 8;17(8):e0010831. doi: 10.1371/journal.pntd.0010831. eCollection 2023 Aug.
2
COVID-19 vaccination strategy in Singapore: perspectives and lessons from primary care.新加坡的2019冠状病毒病疫苗接种策略:基层医疗的观点与经验教训
Singapore Med J. 2024 Dec 1;65(12):681-685. doi: 10.4103/singaporemedj.SMJ-2021-405. Epub 2023 Mar 2.
3
Factors associated with COVID-19 vaccination intent in Singapore, Australia and Hong Kong.
与新加坡、澳大利亚和中国香港的 COVID-19 疫苗接种意愿相关的因素。
Vaccine. 2022 May 9;40(21):2949-2959. doi: 10.1016/j.vaccine.2022.03.062. Epub 2022 Apr 5.
4
Evaluating Rates and Determinants of COVID-19 Vaccine Hesitancy for Adults and Children in the Singapore Population: Strengthening Our Community's Resilience against Threats from Emerging Infections (SOCRATEs) Cohort.评估新加坡人群中成人和儿童对新冠疫苗犹豫的比率及决定因素:加强我们社区抵御新发感染威胁的韧性(SOCRATEs)队列研究
Vaccines (Basel). 2021 Nov 30;9(12):1415. doi: 10.3390/vaccines9121415.
5
Public sentiments towards the use of Wolbachia-Aedes technology in Singapore.公众对新加坡使用沃尔巴克氏体-伊蚊技术的看法。
BMC Public Health. 2021 Jul 18;21(1):1417. doi: 10.1186/s12889-021-11380-w.
6
Projecting the risk of mosquito-borne diseases in a warmer and more populated world: a multi-model, multi-scenario intercomparison modelling study.预测一个更温暖、人口更多的世界中蚊媒疾病的风险:一项多模型、多情景的对比建模研究。
Lancet Planet Health. 2021 Jul;5(7):e404-e414. doi: 10.1016/S2542-5196(21)00132-7.
7
The global burden of yellow fever.全球黄热病负担。
Elife. 2021 Mar 16;10:e64670. doi: 10.7554/eLife.64670.
8
Yellow fever in Asia-a risk analysis.亚洲的黄热病——风险分析。
J Travel Med. 2021 Apr 14;28(3). doi: 10.1093/jtm/taab015.
9
The Absence of Yellow Fever in Asia: History, Hypotheses, Vector Dispersal, Possibility of YF in Asia, and Other Enigmas.亚洲无黄热病:历史、假说、媒介传播、亚洲出现黄热病的可能性及其他未解之谜。
Viruses. 2020 Nov 25;12(12):1349. doi: 10.3390/v12121349.
10
Risk of yellow fever virus transmission in the Asia-Pacific region.亚太地区的黄热病病毒传播风险。
Nat Commun. 2020 Nov 16;11(1):5801. doi: 10.1038/s41467-020-19625-9.